BSE filing, NSE: SWASTIVI. Summary written from the filing by ALFA Finder's alert engine.
Swasti Vinayaka Synthetics Ltd: key numbers
- Share price
- ₹3.43
- Market cap
- ₹30.87 Cr
- Revenue (annual)
- ₹32.03 Cr
- Net profit (annual)
- ₹3.05 Cr
- P/E (TTM)
- 9.2×Sector 50.0×
- Promoter holding
- 51.00%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Swasti Vinayaka Synthetics Ltd
All →Swasti Vinayaka Synthetics Annual General Meeting
Swasti Vinayaka Synthetics Ltd held its 44th Annual General Meeting on September 29, 2026. Shareholders approved routine business items, director appointments, and related party transactions.
Swasti Vinayaka Synthetics Other Announcement
Swasti Vinayaka Synthetics informed shareholders of the web-link for accessing the FY 2025-26 Annual Report, as per Regulation 36(1)(b).
Swasti Vinayaka Synthetics Annual Report
Swasti Vinayaka Synthetics Ltd has submitted its Annual Report for the financial year ended March 31, 2026, as required under SEBI LODR regulations.
Swasti Vinayaka Synthetics Annual General Meeting
Swasti Vinayaka Synthetics Limited has issued the notice for its 44th Annual General Meeting scheduled for September 29, 2026, to address financial statements and director appointments.
Swasti Vinayaka Synthetics Annual General Meeting
Swasti Vinayaka Synthetics Ltd will hold its 44th Annual General Meeting on September 29, 2026. The company also approved the Board's Report for FY 2025-26.
Swasti Vinayaka Synthetics Management Change
Mrs. Shilpa Dinesh Poddar and Mr. Prabhat Dinesh Poddar have resigned as Non-Executive Directors of Swasti Vinayaka Synthetics Ltd, effective September 1, 2026.
Other other announcement announcements
All →Robokidz Eduventures Other Announcement
Robokidz Eduventures filed its quarterly shareholding pattern for the period ended 30 September 2026. This is routine SEBI Regulation 31 disclosure with no transaction or corporate event.
Natco Pharma Other Announcement
Natco Pharma filed its shareholding pattern with a reporting date of 23 October 2026. Promoter and promoter group hold about 46% of total equity.
Innomet Advanced Materials Other Announcement
Innomet Advanced Materials filed its half-year Reg 32 statement on preferential issue proceeds, with no deviation. Rs.753.25 lakh raised in August 2026 was fully used for working capital.
CCME Global Other Announcement
CCME Global disclosed insider trades by two connected persons, acquiring 90 lakh and 22.5 lakh shares on 28 October 2026. Combined consideration is stated as Rs.112.50 Crore.
- Value
- ₹112.5 Cr
Jay Jalaram Technologies Other Announcement
Jay Jalaram Technologies named its KMP as authorised persons for materiality determination under Regulation 30. This administrative listing carries no financial or business impact.
SPR Auto Technologies Other Announcement
SPR Auto Technologies filed its quarterly QIP monitoring agency report for the quarter ended September 30, 2026. The report found no deviation from the issue objects.